|
KEGG term
|
Count
|
%*
|
P value (EASE score)
|
Fold enrichment
|
|---|
|
Cell Cycle
|
32
|
1.18
|
7.96E-04
|
1.83
|
|
Lysosome
|
29
|
1.07
|
2.49E-03
|
1.77
|
|
Apoptosis
|
22
|
0.81
|
7.43E-03
|
1.80
|
|
Prostate cancer
|
22
|
0.81
|
9.73E-03
|
1.76
|
|
Sphingolipid metabolism
|
12
|
0.44
|
1.52E-02
|
2.19
|
|
TGF-beta signaling pathway
|
21
|
0.78
|
1.53E-02
|
1.72
|
|
Nucleotide excision repair
|
12
|
0.44
|
3.62E-02
|
1.95
|
|
Pancreatic cancer
|
17
|
0.63
|
3.77E-02
|
1.68
|
|
N-Glycan biosynthesis
|
12
|
0.44
|
4.86E-02
|
1.86
|
|
mTOR signaling pathway
|
13
|
0.48
|
5.17E-02
|
1.78
|
|
Aminoacyl-tRNA biosynthesis
|
11
|
0.41
|
5.20E-02
|
1.91
|
|
Glycine serine and threonine metabolism
|
9
|
0.33
|
5.85E-02
|
2.07
|
|
Bladder cancer
|
11
|
0.41
|
6.01E-02
|
1.87
|
|
Pathways in cancer
|
57
|
2.11
|
6.03E-02
|
1.24
|
|
Glutathione metabolism
|
12
|
0.44
|
8.14E-02
|
1.71
|
|
Nitrogen metabolism
|
7
|
0.26
|
9.14E-02
|
2.17
|
|
Non-homologous end-joining
|
5
|
0.19
|
9.65E-02
|
2.74
|
- *Indicates the percentage of genes in each pathway from 2702 genes mapped to KEGG.
